Friday, August 10, 2012

Health - Google News: Amgen, Citing Weak Results, Halts Study of a Cancer Drug - New York Times

Health - Google News
Google News
Amgen, Citing Weak Results, Halts Study of a Cancer Drug - New York Times
Aug 9th 2012, 23:39


CollegeNews

Amgen, Citing Weak Results, Halts Study of a Cancer Drug
New York Times
Amgen is halting a late-stage clinical trial of an experimental drug for pancreatic cancer after an outside monitoring panel concluded that the drug was unlikely to improve the survival of patients with an advanced form of the disease.
Amgen's Drug Trial Ends in FailureSan Fernando Valley Business Journal
Amgen Halts Pancreatic Cancer Trial After Drug FailureBusinessweek
Amgen halts pancreatic cancer drug trialCBS News
FierceBiotech -MarketWatch
all 50 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More